Evidence map›Paper›PMID 35484570›Full record

ArticleInfectious diseases of poverty2022

High infection rates for onchocerciasis and soil-transmitted helminthiasis in children under five not receiving preventive chemotherapy: a bottleneck to elimination.

Hugues C Nana-Djeunga, Linda Djune-Yemeli, André Domche, Cyrille Donfo-Azafack, Arnauld Efon-Ekangouo, Cédric Lenou-Nanga, Narcisse Nzune-Toche, Yves Aubin Balog, Jean Gabin Bopda, Stève Mbickmen-Tchana and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Hugues C Nana-Djeunga *Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon. nanadjeunga@crfilmt.org.ORCID http://orcid.org/0000-0002-4496-6048
Linda Djune-Yemeli *Centre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
André DomcheCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Cyrille Donfo-AzafackCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Arnauld Efon-EkangouoCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Cédric Lenou-NangaCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Narcisse Nzune-TocheCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Yves Aubin BalogCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Jean Gabin BopdaCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Stève Mbickmen-TchanaCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon.
Tirumalaisamy P VelavanInstitute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Véronique Penlap-BengDepartment of Biochemistry, Faculty of Science, University of Yaoundé I, Yaoundé, Cameroon.
Francine NtoumiFondation Congolaise pour la Recherche Médicale (FCRM), CG-BZV, Brazzaville, Republic of the Congo.
Joseph KamgnoCentre for Research on Filariasis and other Tropical Diseases (CRFilMT), Yaoundé, Cameroon. kamgno@crfilmt.org.
Université de Yaoundé I · CMFondation Congolaise Pour La Recherche Médicale · CGInstitut de Recherches Géologiques et Minières · CMUniversity of Tübingen · DE

Funding

European and Developing Countries Clinical Trials Partnership EDCTP-RegNet2015-1045
6 · The paper itself

Abstract

backgroundThe current mainstay for control/elimination of onchocerciasis and soil-transmitted helminthiasis (STH) relies on ivermectin- and mebendazole/albendazole-based preventive chemotherapies. However, children under five years of age have been excluded in both research activities and control programs, because they were believed to have insignificant infection rates. There is therefore a need for up-to-date knowledge on the prevalence and intensity of STH and onchocerciasis infections in this age group. This study aimed at assessing the rates and intensities of onchocerciasis and STH infections in children under five years of age who are excluded from ivermectin- or mebendazole/albendazole-based preventive chemotherapies.

methodsA series of cross-sectional surveys was conducted in four Health Districts in the Centre and Littoral Regions of Cameroon between 2018 and 2019. All subjects aged 2 to 4 years, were screened for prevalence (or infection rate) and intensity [number of eggs per gram of stool (epg) or number of microfilariae per skin snip (mf/ss)] of STH and onchocerciasis infections respectively using the Kato-Katz and skin snip methodologies. Chi-square and the non-parametric tests (Mann Whitney and Kruskal Wallis) were used to compare infection rates and intensities of infections between Health Districts and genders, respectively.

resultsA total of 421 children were enrolled in this study. The overall prevalence of onchocerciasis was 6.6% [95% confidence interval (CI): 4.3‒9.9], ranging from 3.6% (in the Ntui Health District) to 12.2% (in the Bafia Health District). The intensity of infection ranged from 0.5 to 46 microfilariae per skin snip [median: 5; interquartile range (IQR): 2.25‒8.5]. The overall prevalence of STH was 9.6% (95% CI: 6.5‒13.9), with a high infection rate (29.6%) in the Akonolinga Health District. Two STH species (Ascaris lumbricoides and Trichuris trichiura) were found among infected individuals. The median intensities of STH infections were 1,992 epg (IQR: 210‒28,704) and 96 epg (IQR: 48‒168) for A. lumbricoides and T. trichiura, respectively.

conclusionsThis study reveals that children < 5 years of age are highly infected with STH and onchocerciasis, and could contribute to the spread of these diseases, perpetuating a vicious circle of transmission and hampering elimination efforts. These findings reveal the urgent need to provide (or scale) treatments (likely pediatric formulations) to these preschool-aged children, especially in areas of high transmission, to accelerate efforts to reach WHO 2030 target.

Indexed as

HelminthiasisOnchocerciasisAlbendazoleAnimalsChildChild, PreschoolCross-Sectional StudiesFemaleHumansIvermectinMaleMebendazoleSoilAlbendazoleIvermectinMebendazoleSoilCameroonChildren under fiveOnchocerciasisPreventive chemotherapySoil-transmitted helminthiasis

Identifiers

PMID35484570
PMCPMC9052501
OpenAlexW4225162957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.